Teladoc Health (TDOC) Return on Equity (2015 - 2026)

Teladoc Health has disclosed Return on Equity across 12 years of filings, most recently posting 0.0% for Q1 2026.

• Return on Equity for Q1 2026 came in at 0.0%, up 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (up 1.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Equity came in at 0.0% for Q1 2026 at Teladoc Health, up from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.0% in Q4 2023 to a low of 0.03% in Q4 2022.
• The 5-year median for Return on Equity is 0.01% (2024), against an average of 0.01%.
• Across the five-year window, Return on Equity slipped 3 bps in 2022 and advanced 3 bps in 2023, its largest moves.
• Teladoc Health's Return on Equity stood at 0.03% in 2022, then soared by 97 bps to 0.0% in 2023, then tumbled by 600 bps to 0.01% in 2024, then soared by 78 bps to 0.0% in 2025, then advanced by 13 bps to 0.0% in 2026.
• The last three Return on Equity figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.